Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin Loading Dose in Critically Ill Patients
NCT02117986Phase 4Unknown
- Sponsor
- Hospital Barros Luco Trudeau
- Start
- Apr 2014
- Primary completion
- Dec 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of colistin in Gram-negative bacterial infection, sponsored by Hospital Barros Luco Trudeau. Status: unknown.
02
Drugs
colistin
03
Conditions
Gram-negative bacterial infection
Beyond the preview
Go deeper on NCT02117986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02117986.